First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studies.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Antipsychotic long-acting injections (LAIs) are often used in an attempt to improve medication adherence in people with schizophrenia.

Related collections

Author and article information

Journal

PubMed ID:: 19880913

DOI:: 10.1192/bjp.195.52.s20

Data availability:

Comments

Comment on this article

scite_

First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studies.

Read this article at

Global Health Next Generation Network

Journal

Comment on this article